Angel
Salgado Barreira
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (11)
2024
-
Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study
Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 539-546
2023
-
Colchicine and risk of hospitalization due to COVID-19: A population-based study
Journal of Medical Virology, Vol. 95, Núm. 2
-
Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase
Primary Care Diabetes, Vol. 17, Núm. 4, pp. 366-372
-
Effect of Previous Anticoagulant Treatment on Risk of COVID-19
Drug Safety, Vol. 46, Núm. 3, pp. 273-281
-
Effect of dapagliflozin on COVID-19 infection and risk of hospitalization
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2335-2342
-
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis
Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75
-
RE: Colchicine and risk of hospitalization due to COVID-19: A population-based study
Journal of Medical Virology
2022
-
Semaglutide versus GLP-1 agonists. Effectiveness, safety, and quality of life in patients with diabetes mellitus 2. The SEVERAL study
Farmacia Hospitalaria, Vol. 46, Núm. 6, pp. 372-379
2021
-
Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part i: A diagnostic accuracy meta-analysis
Journal of Personalized Medicine, Vol. 11, Núm. 6
-
Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part ii: A cancer risk meta-analysis
Journal of Personalized Medicine, Vol. 11, Núm. 7
2020
-
Association of salivary human papillomavirus infection and oral and oropharyngeal cancer: A meta-analysis
Journal of Clinical Medicine, Vol. 9, Núm. 5